获批创新器械！全球首款侵入式脑机接口系统

Core Viewpoint - The approval of the first invasive brain-computer interface (BCI) medical device by the National Medical Products Administration marks a significant milestone in clinical applications, with the company BoRuiKang Medical Technology (Shanghai) Co., Ltd. initiating its IPO process simultaneously [1][4]. Group 1: Product Overview - The approved product consists of a brain-computer interface implant, an electrode kit, a signal transceiver, a pneumatic glove device, a surgical toolkit, and software for decoding brain signals and clinical management [3]. - It is designed for patients aged 18 to 60 with cervical spinal cord injuries resulting in quadriplegia, specifically those with stable conditions for at least six months [3]. Group 2: Technology and Innovation - The NEO system, developed in collaboration with Tsinghua University, utilizes a minimally invasive approach with a wireless power and communication design, avoiding direct contact with brain tissue [4][5]. - Clinical trials have shown significant improvements in hand function for participants, with some achieving independent grasping and basic daily activities [5]. Group 3: Market Growth - The global implanted BCI market is projected to grow from approximately $153 million in 2026 to about $252 million by 2030, with a compound annual growth rate (CAGR) of around 13% [6]. - The Chinese BCI market is expected to reach approximately 46 billion yuan in 2026, with long-term projections suggesting it could exceed 120 billion yuan by 2040 [6]. Group 4: Policy and Industry Dynamics - The BCI technology has been included in China's "14th Five-Year Plan," with government support aimed at achieving key technological breakthroughs by 2027 [7]. - The competitive landscape is intensifying, with BoRuiKang leading in semi-invasive technology while other companies pursue fully invasive approaches [7]. Group 5: Future Outlook - The BCI industry is transitioning from research to commercialization, with BoRuiKang's NEO system positioning Chinese enterprises favorably in this emerging market [8]. - The potential for large-scale application of BCI technology could create new opportunities in the medical industry, particularly for the rehabilitation of millions of spinal cord injury patients [8].